11/02/2026
The progressive loss of dopaminergic neurons in affected patient brains is one of the pathological features of Parkinson’s disease, the second most common human neurodegenerative disease. Although the detailed pathogenesis accounting for dopaminergic neuron degeneration in Parkinson’s disease is still unclear, the advancement of stem cell approaches has shown promise for Parkinson’s disease research and therapy.
Researchers from National Neuroscience Institute and Duke-NUS Medical School discussed the practical approaches and potential applications of induced pluripotent stem cell techniques for generating and differentiating dopaminergic neurons from induced pluripotent stem cells.
They concluded that the discovery of current stem cell techniques for deriving induced pluripotent stem cells (iPSCs) from differentiated cells and further differentiation into distinct lineages of cells has opened new avenues of research, including in the field of neurobiology.
Read more in Neural Regeneration Research, Wolters Kluwer: https://bit.ly/46LlKZ6
AMC researchers involved: Ling-Xiao Yi, Genevieve Saw, Li Zeng, Eng King Tan, Zhi D**g Zhou
Visit Academic Medicine Research Institute - AMRI at https://www.singhealthdukenus.com.sg/research